IQVIA™ Real-World Insights Bibliography

Cost of illness: estimating direct healthcare costs related to obesity in a Japanese clinical setting
Author(s): Riku Ota 1, Koki Idehara 2, Hiroyuki Matsuda 2, Ronald Filomeno 2, J Baker-Knight 3 (rwesheorj 2)
Affiliations(s): 1) Novo Nordisk Pharma Ltd., Nerima, 13, Japan 2) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan 3) Novo Nordisk, 2900, Denmark
Publication(s):  ISPOR
Value in Health
Document Type(s): Abstract, Conference, Poster, Presentation,
Countries: Japan,
Click here for the abstract
C:
Y:
Endocrinology,
2023
  L:
A:
English
Cost of illness, Database Study,
  Add to report
 
 
Burden of caregivers of patients with neuronopathic and non-neuronopathic Gaucher disease in Japan: a survey-based study
Author(s): Yuta Koto 1, Aya Narita 2, Shinichi Noto 3, Masafumi Okada 4, Midori Ono 5, Terumi Baba 5, Rieko Sagara 5, Norio Sakai 1 (rwesheorj 4)
Affiliations(s): 1) Child Healthcare and Genetic Science Laboratory, Division of Health Sciences, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-shi, Osaka 565-0871, Japan 2) Division of Child Neurology, Institute of Neurological Science, Tottori University Faculty of Medicine, 86 Nishi-cho, Yonago-shi, Tottori 683-8503, Japan 3) Department of Rehabilitation, Niigata University of Health and Welfare, 1398 Shimami-cho, Kita-ku, Niigata-shi, Niigata 950-3198, Japan 4) Real-World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., 4-10-18 Takanawa, Minato-ku, Tokyo 108-0074, Japan 5) Japan Medical Office, Takeda Pharmaceutical Company Limited, 2-1-1 Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8688, Japan
Publication(s):  Molecular Genetics and Metabolism Reports
Document Type(s): Article, Online article,
Countries: Japan,
Click here for the abstract
C:
Y:
Endocrinology, Neurological disorders,
2023
  L:
A:
English
Patient questionnaire, Survey research,
  Add to report
 
 
Concomitant Medication Use in the Treatment Journey of Pulmonary Arterial Hypertension Patients: A Canadian Retrospective Claims Analysis
Author(s): Essam Ibrahim1, Assem Al-Akabawi1, Moses Dawodu1, Juejing Ling2, Irene Wang2, Brad Millson3
Affiliations(s): 1Janssen Canada Inc, Toronto, ON, Canada; 2IQVIA Solutions Canada Inc., Mississauga, ON, Canada; 3IQVIA Solutions Canada Inc., Kanata, ON, Canada
Publication(s): 
Document Type(s): Poster,
Countries: Canada,
C:
Y:
Endocrinology,
2022
  L:
A:
English
Clinical setting: hospital, Clinical setting: Primary care, direct to patient research, Observational study,
  Add to report
 
 
Patient preferences for growth hormone treatment in Japanese children
Author(s): Toshiaki Tanaka 1, Takahiro Sato 2, Akira Yuasa 3, Takeshi Akiyama 4, Adeeb Tawseef 4 (rwesheorj 4)
Affiliations(s): 1) Tanaka Growth Clinic, Tokyo, Japan 2) Medical Affairs, Rare Disease, Pfizer Japan Inc, Tokyo, Japan 3) Corporate Affairs, Health and Value, Pfizer Japan Inc, Tokyo, Japan 4) IQVIA Solutions Japan K.K., RWE & HEOR, Tokyo, Japan
Publication(s):  Pediatrics International
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Endocrinology,
2021
  L:
A:
English
Patient questionnaire, Survey research,
  Add to report
 
 
An Assessment of Physician Reasons for Prescribing Insulin Lispro 200 units/ml in a Prefilled Pen in Germany
Author(s): Chen J1, Perez-Nieves M1, Piras De Oliveira C1, Spaepen E2, Osumili B3, Ling Poon J1, Schloot N2, Lara N4, Garcia Alvarez L4, Roset M4, Lennartz D5
Affiliations(s): 1 Lilly and Company, Indianapolis, US 2 Eli Lilly and Company Deutschland GmbH, Bad Homburg, Germany 3 Eli Lilly and Company, Surrey, UK 4 IQVIA, Barcelona, Spain 5 IQVIA, Munich, Germany
Publication(s):  ECE, Lyon, France, 18-21 May 2019
Document Type(s): Poster,
Countries: Germany,
Click here for the abstract
C:
Y:
Endocrinology,
2019
  L:
A:
English
Survey research,
  Add to report
 
 
Cinacalcet Persistence and Adherence in France, Germany, and Italy
Author(s): Dionne M. Hines1, Catherine B. McGuiness1, Rolin L. Wade1, Bruno Fouqueray2, Paul Dluzniewski2
Affiliations(s): 1QuintilesIMS, 2Amgen
Publication(s):  54th ERA-EDTA Congress
Document Type(s): Poster,
Countries: France, Germany, Italy,
C:
Y:
Endocrinology, Nephrology,
2017
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Drug interactions with levothyroxine therapy in patients with hypothyroidism: observational study in general practice.
Author(s): Trifirò G1, Parrino F, Sultana J, Giorgianni F, Ferrajolo C, Bianchini E, Medea G, Benvenga S, Cricelli I, Cricelli C, Lapi F.
Affiliations(s): Department of Clinical and Experimental Medicine, Pharmacology section, University of Messina, Messina, Italy
Publication(s):  Clin Drug Investig. 2015 Mar;35(3)
Document Type(s): Abstract,
Countries: Italy,
C:
Y:
Endocrinology,
2015
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan.
Author(s): Shortridge EF1, Polzer P2, Donga P3, Wade RL3
Affiliations(s): 1 Spine and Biologics, Medtronic Inc., Memphis, TN, USA. 2 Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA. 3 Health Economics and Outcomes Research, IMS Health, Plymouth Meeting, PA, USA.
Publication(s):  Int J Clin Pract. 2015 Jul;69(7):783-90.
Document Type(s): Article,
Countries: USA,
C:
Y:
Diabetes, Endocrinology,
2015
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Autoimmune thyroiditis as a risk factor for stroke: a historical cohort study
Author(s): Karch A & Thomas SL
Affiliations(s): Department of Epidemiology (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Faculty of Epidemiology & Population Health (A.K., S.L.T.), London School of Hygiene and Tropical Medicine, UK; and Department of Neurology (A.K.), University Medical Center Göttingen, Germany.
Publication(s):  Neurology. 2014 May 6;82(18):1643-52.
Document Type(s): Article,
Countries: UK,
Click here for the abstract
C:
Y:
Cardiovascular disease, Endocrinology, Immunology and Vaccination, Neurological disorders,
2014
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women.
Author(s): Enrico Papaleo,1 Carlo Alviggi,2 Giorgio Lorenzo Colombo,3,4 Claudio Pisanelli,5,6 Claudio Ripellino,7 Salvatore Longobardi,8 and Pier Luigi Canonico9
Affiliations(s): Centro Scienze della Natalità, Gynecological-Obstetrics Department, San Raffaele Hospital, Vita-Salute San Raffaele, Milan, Italy 2Department of Neuroscience, Reproductive Sciences and Odontostomatology, University “Federico II” of Naples, Naples, Italy 3Department of Drug Sciences, University of Pavia, Pavia, Italy 4SAVE Studi Analisi Valutazioni Economiche, Milan, Italy 5ACO San Filippo Neri, Rome, Italy 6Società Italiana Di Farmacia Ospedaliera, Milan, Italy 7CSD Medical Research Srl, Milan, Italy 8Medical Department, Merck Serono SpA, Rome, Italy 9Department of Pharmaceutical Sciences, University of Piemonte Orientale, Novara, Italy
Publication(s):  Ther Clin Risk Manag. 2014 Jun 25;10:479-84
Document Type(s): Article,
Countries: Italy,
Click here for the abstract
C:
Y:
Endocrinology, Womens Health,
2014
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
 1 of 5 Next Page Last Page